Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (5y) (2014 - 2024)
Xtl Biopharmaceuticals (XTLB) EPS (Diluted) Growth (5y) (2014 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -25.79% |
| Sep 30, 2024 | 1,399.82% |
| Jun 30, 2024 | -872.35% |
| Mar 31, 2024 | 752.05% |
| Dec 31, 2023 | 12.63% |
| Sep 30, 2023 | 1,201.18% |
| Mar 31, 2023 | -1,177.60% |
| Dec 31, 2022 | -122.18% |
| Sep 30, 2022 | -736.38% |
| Jun 30, 2022 | -832.15% |
| Mar 31, 2022 | 605.82% |
| Dec 31, 2021 | -719.17% |
| Sep 30, 2021 | -1,359.19% |
| Jun 30, 2021 | 1,244.75% |
| Mar 31, 2021 | 918.30% |
| Dec 31, 2020 | -14.88% |
| Sep 30, 2020 | -14.44% |
| Jun 30, 2020 | 22.73% |
| Dec 31, 2019 | -8.67% |
| Sep 30, 2019 | -14.87% |